+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Tennis Elbow Diagnosis and Treatment Market Research and Forecast, 2019-2025

  • PDF Icon


  • April 2019
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4770674
Global Tennis Elbow (Lateral Epicondylitis) Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Diagnosis (X-ray, MRI Scan and EMG), by Treatment (Surgical and Non-Surgical Treatment (Shock wave Therapy, Painkiller & NSAIDS, Corticosteroid Injection, and Equipment & Other Product)) and Forecast, 2019-2025.

Tennis Elbow referred to lateral epicondylitis, is a pain centered outside the arm, where forearm meets elbow. It is a type of tendinitis, which results in swelling of tendons and is recognized on medical examination. Tennis elbow is an inflammatory condition observed more often in baseball players, tennis players, woodworkers, swimmers and any individual who repeat an arm motion again and again. The condition increases on broadening wrist against the obstruction. This injury is not restricted to tennis or baseball only; cricketers & athletes who are using improper equipment are also suffering from tennis elbow. This injury can be diagnosed through various imaging tests such as electromyography (EMG), X-ray or MRI (Magnetic resonance imaging). Usually, people of age group 35-50 years are suffering from tennis elbow due to the weakening of tendons.

Increasing sports injury, growing tendons bump, and raising awareness among people are some of the drivers which contribute to the tennis elbow market. Although, a side effect of treatments is restraining the growth of the tennis elbow market. The tennis elbow diagnosis and treatment market are segmented on the base of diagnosis and treatment type. Diagnosis segment is further segmented into X-Rays, MRI Scan and EMG. Whereas, the treatment segment is further segmented into surgical and nonsurgical treatment. Surgical treatment of tennis elbow includes open surgery and arthroscopic surgery. Whereas, Non-surgical treatment segment is further segmented into painkiller and NSAIDs, corticosteroid injections, shock wave therapy, equipment and other. Painkillers and NSAIDS are primarily used by tennis elbow sufferers. However, in severe condition, corticosteroid injections and shock wave therapy can be used for further relief. Moreover, equipment such as braces or strap is also available in the market, which helps in reducing stress on elbow tendons. In addition, extracorporeal shock wave therapy intended to promote the body’s natural healing process.

Geographically, the tennis elbow market is segmented into the major region, which includes North America, Europe, Asia-pacific and Rest of the world. Increasing sports events in the region such as North America and Europe are expected to drive the global tennis elbow diagnosis and treatment market. There are some players in the tennis elbow market such as Pfizer, Inc., Mylan N.V., and GlaxoSmithKline PLC providing pain killers and NSAIDs in the market. whereas, elbow braces manufacturers are also significantly contributing to the market such as BioSkin, Inc., BraceAbility, Inc., McDavid, Inc. and BTL Corporate.

Research Methodology

The market study of the global tennis elbow market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog

The report is intended for the medical device companies, healthcare provider investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation:
1. Global Tennis Elbow Market Research and Analysis by Diagnosis
2. Global Tennis Elbow Market Research and Analysis by Treatment

The Report Covers:
  • Comprehensive research methodology of the global tennis elbow market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Insights about market determinants which are stimulating the global tennis elbow market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Pfizer, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. GlaxoSmithKline PLC Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Bayer AG Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Arthrex, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. BioSkin, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Tennis Elbow Market by Diagnosis
5.1.1. X-Rays
5.1.2. Magnetic Resonance Imaging (MRI) Scan
5.1.3. Electromyography (EMG)
5.2. Tennis Elbow Market by Treatment
5.2.1. Surgical Treatment Open surgery Arthroscopic surgery
5.2.2. Non-Surgical Treatment Painkiller and NSAIDS Corticosteroid Injections Shock Wave Therapy Equipment and Other
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Arthrex, Inc.
7.2. Bayer AG
7.3. BioSkin, Inc.
7.4. BraceAbility, Inc.
7.5. BTL Corporate
7.6. Catalent, Inc.
7.7. Core Products International, Inc.
7.8. CuraMedix
7.9. DJO, LLC
7.10. GlaxoSmithKline PLC
7.11. IOL Chemicals aend Pharmaceuticals, Ltd.
7.12. Iroko Pharmaceuticals, LLC
7.13. McDavid, Inc.
7.14. Mylan, N.V.
7.15. Nea International B.V.
7.16. Össur Americas
7.17. Pfizer, Inc.
7.18. Recordati Rare Diseases, Inc.
7.19. Tenex Health, Inc.
7.20. Teva Pharmaceutical Industries, Ltd.
* List of Tables and Figures available on enquiry

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bayer AG
  • BioSkin, Inc.
  • BraceAbility, Inc.
  • BTL Corporate
  • Catalent, Inc.
  • Core Products International, Inc.
  • CuraMedix
  • DJO, LLC
  • GlaxoSmithKline PLC
  • IOL Chemicals aend Pharmaceuticals, Ltd.
  • Iroko Pharmaceuticals, LLC
  • McDavid, Inc.
  • Mylan, N.V.
  • Nea International B.V.
  • Össur Americas
  • Pfizer, Inc.
  • Recordati Rare Diseases, Inc.
  • Tenex Health, Inc.
  • Teva Pharmaceutical Industries, Ltd.